FIELD: veterinary virology, biotechnology. SUBSTANCE: invention relates to vaccine used for prophylaxis of Mareck's disease. Virus-vaccine has suspension of chicken SPF-embryo fibroblast cells infected with the strain "VNIIZZH/N 110-DEP" (collection of VGNKI) of turkey herpes virus, cattle serum blood and dimethylsulfoxide. Components are taken in the following ratio, wt. -%: infected cells suspension, 60.0-80.0; cattle serum blood, 15.0-25.0; and dimethylsulfoxide 5.0-15.0. Strain "VNIIZZH/N 110" of turkey herpes virus is used at its biological activity 1 x 105 FOE/cm3., not less. EFFECT: enhanced immunogenic activity of vaccine. 9 cl, 3 tbl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
BIVALENT VACCINE AGAINST MARECK'S DISEASE AND METHOD OF ITS PREPARING | 1999 |
|
RU2144377C1 |
DRY VIRUS-VACCINE AGAINST MARECK'S DISEASE AND METHOD OF ITS PREPARING | 1999 |
|
RU2144376C1 |
VIRUS VACCINE AGAINST MAREK'S DISEASE | 2001 |
|
RU2205660C2 |
MARECK'S DISEASE VIRUS STRAIN 3004/ 109 FOR VACCINE PREPARATION PREPARING | 2001 |
|
RU2199583C1 |
METHOD FOR PREPARING VIRUS-VACCINE AGAINST MARECK'S DISEASE | 2001 |
|
RU2209635C2 |
TURKEY HERPES VIRUS STRAIN "VNIIZZH/N 110" FOR PREPARING VACCINE AGAINST MARECK'S DISEASE | 1999 |
|
RU2144562C1 |
VIRAL VACCINE AGAINST MAREK'S DISEASE | 2009 |
|
RU2410117C1 |
INDUSTRIAL STRAIN "VLADIMIR" OF TURKEY HERPESVIRUS FOR VIRAL VACCINE FOR MAREK'S DISEASE | 2007 |
|
RU2336303C1 |
METHOD FOR OBTAINING BIVALENT VACCINE AGIANTS MAREK'S DISEASE | 2000 |
|
RU2203681C2 |
METHOD OF PRODUCTION OF DRY POLYVALENT VIRUS-VACCINE FOR MAREK'S DISEASE PREVENTION AND DRY POLYVALENT VIRUS-VACCINE FOR MAREK'S DISEASE PREVENTION | 2005 |
|
RU2327488C2 |
Authors
Dates
2000-01-20—Published
1999-06-28—Filed